Skip to main content
. 2015 Jul 6;10(7):e0132352. doi: 10.1371/journal.pone.0132352

Table 6. Stratified analyses on association between rs7248320 genotypes and cervical cancer risk.

Variables Patients/ Controls N (%) OR(95%CI) a P b
AA/GA GG
Age 0.118
≤53 554(79.5)/679(85.3) 143(20.5)/117(14.7) 1.59(1.21–2.10)
>53 567(86.6)/575(87.9) 88(13.4)/79(12.1) 1.13(0.81–1.56)
Smoking status 0.498
Ever 45(86.5)/20(90.9) 7(13.5)/2(9.1) 2.49(0.42–14.79)
Never 1076(82.8)/1234(86.4) 224(17.2)/194(13.6) 1.34(1.09–1.66)
Menopausal status 0.014
Premenopausal 470(78.9)/508(86.5) 126(21.1)/79(13.5) 1.82(1.33–2.48)
Menopause 651(86.1)/746(86.4) 105(13.9)/117(13.6) 1.07(0.80–1.42)
Family history of any cancer 0.830
Yes 210(82.7)/256(86.2) 44(17.3)/41(13.8) 1.41(0.87–2.28)
No 911(83.0)/998(86.6) 187(17.0)/155(13.4) 1.33(1.06–1.68)
Parity 0.305
0–1 455(80.2)/612(86.3) 112(19.8)/97(13.7) 1.6(1.19–2.16)
2 319(83.5)/336(85.1) 63(16.5)/59(14.9) 1.09(0.73–1.62)
>2 347(86.1)/306(88.4) 56(13.9)/40(11.6) 1.29(0.83–2.00)

aAdjusted for age, smoking status, menopausal status, family history of any cancer and parity (excluded the stratified factor in each stratum).

b P-value for the heterogeneity test.